Literature DB >> 7030830

A new genetically obese-hyperglycemic rat (Wistar fatty).

H Ikeda, A Shino, T Matsuo, H Iwatsuka, Z Suzuoki.   

Abstract

The fa-gene was transferred from the Zucker rat (13 M strain) to the Wistar Kyoto (WKY) rat. The survey, performed at the 10th generation of backcrossing, showed that Wistar fatty rats (fa/fa), a congenic strain of WKY, developed obesity and obesity-related features, such as hyperinsulinemia and hyperlipemia, in the same manner as Zucker fatty rats. Males, but not females, showed hyperglycemia, glucosuria, and polyuria as early as 8 wk of age. Tolerance and insulin response to oral glucose were decreased with advancing age in males. The diabetic changes appeared to be caused by an interaction between predisposition to develop diabetes in the WKY rat and fa-induced obesity. This is because WKY rats were found to be less sensitive to insulin than Zucker rats by both the glucose tolerance test and the steady-state blood glucose method which estimates overall insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030830     DOI: 10.2337/diab.30.12.1045

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  35 in total

1.  Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia.

Authors:  L Orci; M Ravazzola; D Baetens; L Inman; M Amherdt; R G Peterson; C B Newgard; J H Johnson; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Spontaneous diabetes in eSS rats.

Authors:  S M Martínez; M C Tarrés; S Montenegro; R Milo; J C Picena; N Figueroa; S R Rabasa
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

3.  Effect of diacylglycerol on the development of impaired glucose tolerance in sucrose-fed rats.

Authors:  Shinichi Meguro; Noriko Osaki; Noboru Matsuo; Ichiro Tokimitsu
Journal:  Lipids       Date:  2006-04       Impact factor: 1.880

4.  Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.

Authors:  Nobuyuki Negoro; Shinobu Sasaki; Satoshi Mikami; Masahiro Ito; Masami Suzuki; Yoshiyuki Tsujihata; Ryo Ito; Ayako Harada; Koji Takeuchi; Nobuhiro Suzuki; Junichi Miyazaki; Takashi Santou; Tomoyuki Odani; Naoyuki Kanzaki; Miyuki Funami; Toshimasa Tanaka; Akifumi Kogame; Shinichiro Matsunaga; Tsuneo Yasuma; Yu Momose
Journal:  ACS Med Chem Lett       Date:  2010-06-18       Impact factor: 4.345

5.  Insulin-independent diabetes mellitus (type II). Spontaneous hypertensive/NIH-corpulent rat.

Authors:  O E Michaelis; D H Patrick; C T Hansen; J J Canary; R M Werner; N Carswell
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

6.  Potassium channel dysfunction in hypothalamic glucose-receptive neurones of obese Zucker rats.

Authors:  I C Rowe; P R Boden; M L Ashford
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

7.  Intermittent dietary restriction in eSS diabetic rats. Effects on metabolic control and skin morphology.

Authors:  S M Martínez; M C Tarrés; S Montenegro; G Revelant; N Figueroa; D Alonso; O M Laudanno; A D'Ottavio
Journal:  Acta Diabetol Lat       Date:  1990 Oct-Dec

8.  Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.

Authors:  Tomoyuki Nishimoto; Yuichiro Amano; Ryuichi Tozawa; Eiichiro Ishikawa; Yoshimi Imura; Hidefumi Yukimasa; Yasuo Sugiyama
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigm.

Authors:  Kousuke Noda; Shintaro Nakao; Souska Zandi; Dawei Sun; K C Hayes; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2014-02-26       Impact factor: 5.191

10.  Rat obesity gene fatty (fa) maps to chromosome 5: evidence for homology with the mouse gene diabetes (db).

Authors:  G E Truett; N Bahary; J M Friedman; R L Leibel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.